Design Therapeutics snags $45m Series A

Design Therapeutics, which is developing treatments for serious degenerative disorders, has raised $45 million in Series A funding.

24 March 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles